The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Psychotropic dose equivalence in Japan
Open accessAbstract
Psychotropic dose equivalence is an important concept when estimating the approximate psychotropic doses patients receive, and deciding on the approximate titration dose when switching from one psychotropic agent to another. It is also useful from a research viewpoint when defining and extracting specific subgroups of subjects. Unification of various agents into a single standard agent facilitates easier analytical comparisons. On the basis of differences in psychopharmacological prescription features, those of available psychotropic agents and their approved doses, and racial differences between J apan and other countries, psychotropic dose equivalency tables designed specifically for Japanese patients have been widely used in J apan since 1998. Here we introduce dose equivalency tables for: (i) antipsychotics; (ii) antiparkinsonian agents; (iii) antidepressants; and (iv) anxiolytics, sedatives and hypnotics available in J apan. Equivalent doses for the therapeutic effects of individual psychotropic compounds were determined principally on the basis of randomized controlled trials conducted in J apan and consensus among dose equivalency tables reported previously by psychopharmacological experts. As these tables are intended to merely suggest approximate standard values, physicians should use them with discretion. Updated information of psychotropic dose equivalence in Japan is available at http://www.jsprs.org/en/equivalence.tables/. [Correction added on 8 July 2015, after first online publication: A link to the updated information has been added.]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033302 · Cited by 910
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., Green-Paden, L. D., Tenhula, W. N., Boerescu, D., Tek, C., et al. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007071 · Cited by 757
Gelder, M. (1983) · Cited by 557
New Oxford Textbook of Psychiatry
Rimes, K. A., & Salkovskis, P. M. (2000) · Oxford University Press eBooks · Cited by 428
Dose equivalence of the anti-psychotic drugs
Davis, J. M. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90071-5 · Cited by 324
Tran, P. V., Dellva, M. A., Tollefson, G. D., Beasley, C. M., Potvin, J. H., & Kiesler, G. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0505 · Cited by 167
Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989
Centorrino, F., Eakin, M., Bahk, W., Kelleher, J. P., Gören, J. L., Salvatore, P., Egli, S., & Baldessarini, R. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1932 · Cited by 105
An Audit of Outpatient Antipsychotic Usage in the Three Health Sectors of Auckland, New Zealand
Humberstone, V., Wheeler, A., & Lambert, T. J. R. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01340.x · Cited by 69
Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment
Sadock, B. J., Sadock, V. A., & Sussman, N. (2001) · Cited by 41
Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan
Binder, R. L., Kazamatsuri, H., Nishimura, T., & McNiel, D. E. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1494 · Cited by 37
A Pilot Effort to Determine Benztropine Equivalents of Anticholinergic Medications
de León, J., Odom-White, A., Simpson, G. M., & Canuso, C. (1994) · Psychiatric Services · doi:10.1176/ps.45.6.606 · Cited by 35
Essentials of Clinical Psychiatry
Schwab, J. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.664 · Cited by 33
Long-term treatment with antidepressants in primary care
Ali, I. M. (1998) · Psychiatric Bulletin · doi:10.1192/pb.22.1.15 · Cited by 24
Current Diagnosis & Treatment in Psychiatry
Ebert, M. H., Loosen, P. T., & Nurcombe, B. (2000) · Medical Entomology and Zoology · Cited by 21
Inada, T., Nozaki, S., Inagaki, A., & Furukawa, T. A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.510 · Cited by 19
Self-citationAre the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials
Furukawa, T. A., Inada, T., Adams, C. E., McGuire, H., Inagaki, A., & Nozaki, S. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-6 · Cited by 7
Self-citation
Cited by
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder
Husain, S. F., Yu, R., Tang, T.-B., Tam, W. W., Tran, B., Quek, T. T., Hwang, S.-H., Chang, C. W., Ho, C. S., & Ho, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-66784-2 · Cited by 213
Oh, J., Jang, S., Kim, H., & Kim, J.-J. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104171 · Cited by 124
Hidese, S., Ota, M., Wakabayashi, C., Noda, T., Ozawa, H., Okubo, T., & Kunugi, H. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.33 · Cited by 81
Cheng, W.-J., Chen, C.-H., Chen, C.-K., Huang, M.-C., Pietrzak, R. H., Krystal, J. H., & Xu, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.049 · Cited by 65
Metadata
- Authors
- Inada, T., & Inagaki, A.
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2015-02-14
- Volume
- 69
- Issue
- 8
- Pages
- 440-447
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W1538814565
- Cited by
- 467
- References
- 18
- FWCI
- 21.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.